GE Aerospace (GE)

Total Costs & Expenses

$11.74B

Quarterly · Period ending: · USD

GE logo

GE Total Costs & Expenses

Latest reported$11.74B
GE Quarterly Total Costs & Expenses ($0.00 → $11.74B)
High-resolution chart · PNG

GE total costs & expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

GE Aerospace Total Costs & Expenses — Quarterly (USD)
Period endingTotal Costs & Expenses (USD)
11,744,000,000
10,860,000,000
9,501,000,000
10,358,000,000
9,425,000,000
8,923,000,000
7,931,000,000
8,206,000,000
8,601,000,000
7,466,000,000
7,669,000,000
18,228,000,000
7,950,000,000
7,579,000,000
13,986,000,000
20,558,000,000
14,430,000,000
13,450,000,000
13,522,000,000
18,849,000,000
17,448,000,000
17,601,000,000
16,575,000,000
20,755,000,000
18,475,000,000
17,876,000,000
18,847,000,000
23,491,000,000
22,084,000,000
21,475,000,000
20,221,000,000
28,340,000,000
22,657,000,000
26,764,000,000
25,629,000,000
32,930,000,000
28,412,000,000
25,775,000,000
24,517,000,000
31,702,000,000
25,082,000,000
24,116,000,000
24,960,000,000
39,542,000,000
23,944,000,000
24,177,000,000
22,955,000,000
59,816,000,000
20,340,000,000
20,616,000,000
19,310,000,000
25,442,000,000
19,881,000,000
19,397,000,000
17,157,000,000
-8,146,000,000
18,844,000,000
19,549,000,000
18,732,000,000
-10,035,000,000
27,866,000,000
27,317,000,000
27,099,000,000
33,208,000,000
27,968,000,000
28,810,000,000
29,374,000,000
34,350,000,000
31,502,000,000
31,333,000,000
30,485,000,000
37,483,000,000
35,107,000,000
33,587,000,000
30,347,000,000
34,187,000,000
30,501,000,000
29,452,000,000
27,239,000,000
31,582,000,000
27,022,000,000
27,185,000,000
28,269,000,000
17,802,000,000
26,719,000,000
27,094,000,000
26,119,000,000
33,858,000,000
29,971,000,000
29,358,000,000
26,235,000,000
28,443,000,000
25,474,000,000
25,608,000,000
23,541,000,000
29,663,000,000
24,598,000,000
25,192,000,000
23,064,000,000
25,903,000,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.